IP Library Granted Patent US 9,119,394
Granted Patent B2
US 9,119,394 · App. 12/774,057 · Granted Sep 1, 2015

Anti-microbial polymers and their compositions

Inventor: Graham J. H. Melrose (Mount Claremount, AU)
Assignee: RECCE PTY LTD.
A01N35/02A01N37/36A01N43/16A61K31/78C08G2/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,119,394
App. No.
12/774,057
Granted
Sep 1, 2015
Kind
B2
Abstract

Polymers derived directly from acrolein monomer that are substantially soluble in water and/or aqueous media, together with methods for preparing same and compositions containing such for use as an anti-microbial, anti-cancer, anti-inflammatory and/or anti-coagulant.

Claims (11)

1. An antimicrobial copolymer for administration to humans or animals comprising polyethylene glycol and acrolein based monomer residues derived from base-catalyzed copolymerization in an aqueous solution of:

(a) polyethylene glycol (PEG) of molecular weight selected from the range of from 200 to 2000 Daltons; and

(b) acrolein based monomer selected from the group consisting of acrolein and/or its acetal derived with an hydroxyl-carboxylic acid;

wherein:

the monomer ratio of PEG:acrolein based monomer residues within the copolymer is in the range of from 1:1 to 1:11;

the copolymer remains soluble in aqueous solution; and

the antimicrobial activity of the copolymer is not from release of acrolein based monomer into aqueous solution.

2. The antimicrobial copolymer according to claim 1 wherein the copolymer is soluble in water at less than pH 4.

3. The antimicrobial copolymer according to claim 1 wherein the copolymer is free of cross-linking or molecular conjugation.

4. The antimicrobial copolymer according to claim 1 comprising structures resulting from reaction between polyethylene glycol and proximate carbons to the carbonyl in acrolein based monomer residues formed during polymerization.

5. The antimicrobial copolymer according to claim 1 wherein the acrolein based monomer comprises acrolein acetal derived with a hydroxyl-alkanoic acid wherein the hydroxyl-alkanoic acid is selected from the group consisting of tartaric acid, lactic acid, glyceric acid, glycolic acid, citric acid and 2-hydroxy-butanoic acid.

Assignments (4)
SECURITY INTEREST Recorded Jun 16, 2025
From: RECCE PHARMACEUTICALS LIMITED; GRAMELE INDUSTRIAL HOLDINGS PTY LIMITED
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P., AS AGENT
Reel/Frame 071420/0403 →
CHANGE OF NAME Recorded Mar 8, 2018
From: RECCE LIMITED
To: RECCE PHARMACEUTICALS LTD
Reel/Frame 045528/0431 →
CHANGE OF NAME Recorded Sep 25, 2015
From: RECCE PTY LTD.
To: RECCE LIMITED
Reel/Frame 036689/0442 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2010
From: MELROSE, GRAHAM J. H.
To: RECCE PTY LTD.
Reel/Frame 024625/0120 →
Priority Claims (3)
AU 2007906124 · Nov 7, 2007 · national
AU 2007906829 · Dec 14, 2007 · national
AU 2008903576 · Jul 11, 2008 · national
Continuity (2)
Continuation In Part PCTAU2008001140 · Aug 6, 2008
Related Publication 20100266527A1 · Oct 21, 2010